VHT ETF Analysis

Diese Seite wurde per KI maschinell aus dem englischen Original übersetzt; die englische Fassung ist maßgeblich. Englische Fassung lesen

Nur zu Informationszwecken. Keine Finanzberatung.

Kurzantwort

VHT ETF has a last stored price of $311.90, as of the Oct 2, 2026 trading session. Holdings and weights below are as of Mar 15, 2026.

In the stored portfolio snapshot, the largest listed holding is Eli Lilly and Co (LLY) at 12.70%.

VHT ETF — Price, Holdings & Analysis

ETF-Übersicht

VHT provides targeted exposure to the health care sector. The fund's strategy focuses on large-cap companies, with Eli Lilly and Co (LLY) representing the largest allocation at 12.70%, followed by Johnson & Johnson (JNJ) at 8.22% and AbbVie Inc (ABBV) at 6.00%. This concentrated approach allows investors to gain specific exposure to leading companies within the pharmaceutical, biotechnology, and health care equipment industries. The fund's selection methodology prioritizes established companies with significant market capitalization, potentially offering stability compared to broader health care ETFs. VHT may appeal to investors seeking a focused approach to health care investing, but its concentrated nature warrants careful consideration. Past performance does not guarantee future results.

Risikokennzahlen

VHT's concentrated portfolio introduces a higher level of concentration risk compared to more diversified health care ETFs. The top holding, Eli Lilly and Co (LLY), accounts for 12.70% of the fund, meaning its performance significantly impacts VHT's overall returns. The fund's beta of 0.73 suggests lower volatility compared to the broader market, but the concentrated nature of the holdings could still lead to significant price fluctuations. Investors should also consider the potential impact of regulatory changes and drug pricing pressures on the pharmaceutical and biotechnology industries, which could disproportionately affect VHT due to its sector focus. Past performance does not guarantee future results.

Beta: 0.73

Was hält VHT?

Position	Gewichtung
Eli Lilly and Co (LLY)	12.70%
Johnson & Johnson (JNJ)	8.22%
AbbVie Inc (ABBV)	6.00%
Merck & Co Inc (MRK)	4.19%
UnitedHealth Group Inc (UNH)	3.96%
Thermo Fisher Scientific Inc (TMO)	3.33%
Abbott Laboratories (ABT)	2.90%
Amgen Inc (AMGN)	2.80%
Intuitive Surgical Inc (ISRG)	2.75%
Gilead Sciences Inc (GILD)	2.68%

Bestände und Gewichtungen zum 15. März 2026. Diese Fondsdaten sind älter als 45 Tage; prüfen Sie die aktuellen Bestände beim Emittenten.

Dividendenrendite

1.03%

Fragen & Antworten

What is VHT and what does it track?

VHT is an exchange-traded fund (ETF) that provides focused exposure to the health care sector. Unlike broader health care ETFs, VHT holds a very.

The fund's top holdings include companies like Eli Lilly and Co (LLY), Johnson & Johnson (JNJ), and AbbVie Inc (ABBV).

What are the top holdings in VHT?

VHT's top holdings are heavily weighted towards leading companies in the pharmaceutical and health care sectors.

As of 2026-03-15, the top three holdings are Eli Lilly and Co (LLY) at 12.70%, Johnson & Johnson (JNJ) at 8.22%, and AbbVie Inc (ABBV) at 6.00%.

Is VHT a good long-term investment?

Whether VHT is a suitable long-term investment depends on an individual investor's risk tolerance, investment objectives, and time horizon. VHT offers focused exposure to the health care sector through a concentrated portfolio.

The fund's beta of 0.73 suggests lower volatility compared to the broader market, but the concentrated nature of the holdings could still lead to significant price fluctuations.

How does VHT compare to similar ETFs?

VHT distinguishes itself from other health care ETFs through its highly.

While specific expense ratio and AUM data are unavailable, the fund's strategy of focusing on a small number of large-cap companies sets it apart from more diversified health care ETFs. Investors seeking targeted exposure to leading companies within the pharmaceutical and biotechnology industries may find VHT appealing.

Does VHT pay dividends?

Yes, VHT distributes dividends to its shareholders. As of 2026-03-15, VHT has a dividend yield of 1.03%. The dividend yield represents the annual dividend income received from the fund, expressed as a percentage of the fund's net asset value.

Investors seeking income from their investments may find VHT's dividend yield attractive, but it's important to note that dividend yields can fluctuate over time. Past performance does not guarantee future results.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Führen Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Daten dienen ausschliesslich zu Informationszwecken.

Maschinell geschrieben, nicht Seite für Seite geprüft. Die redaktionelle Kontrolle ist systemisch: Regeln und Quellen werden geprüft, einzelne Seiten nicht.